XFOR- X4 Pharmaceuticals, Inc

Name: X4 Pharmaceuticals, Inc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

X4 Pharmaceuticals, Inc (XFOR) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. XFOR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Craig Adam R	2.33M	$9.60M	-
Pres	Volpone John	2.33M	$9.60M	-
CFO	Kirske David	1.55M	$6.40M	-
Dir	Stewart Murray	0	-	-
Dir	Wyzga Michael S	0	-	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 18, 2023	Wyzga Michael S	Director	Buy	25,000	$1.20	$29,875.00	+48.4%	-34.0%	-40.1%
Aug 10, 2023	Stewart Murray	Interim Chief Medical Officer	Sell	130,056	$1.06	$137,859.36	-47.0%	-29.5%	-40.0%
Jun 30, 2023	Dibiase Mary71	Chief Operating Officer	Sell	464	$1.89	$876.96	-0.3%	-44.8%	-70.1%
Jun 30, 2023	Mostafa Adam S.75	Chief Financial Officer	Sell	2,641	$1.89	$4,991.49	-3.2%	-44.8%	-70.1%
Jun 23, 2023	Mostafa Adam S.75	Chief Financial Officer	Sell	5,417	$1.93	$10,454.81	-6.1%	-46.4%	-48.5%
Jun 23, 2023	Dibiase Mary71	Chief Operating Officer	Sell	857	$1.93	$1,654.01	-0.6%	-46.4%	-48.5%
Jun 23, 2023	Ragan Paula77	President And CEO	Sell	6,724	$1.92	$12,910.08	-1.2%	-46.4%	-48.5%
Jun 15, 2023	Dibiase Mary71	Chief Operating Officer	Sell	857	$2.23	$1,911.11	-0.6%	-47.1%	-55.1%
Jun 15, 2023	Mostafa Adam S.75	Chief Financial Officer	Sell	5,417	$2.22	$12,025.74	-5.8%	-47.1%	-55.1%
Jun 15, 2023	Ragan Paula77	President And CEO	Sell	6,724	$2.23	$14,994.52	-1.2%	-47.1%	-55.1%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC